Price Alert

Vincerx Pharma Inc. (VINC)

NASDAQ: VINC · Real-Time Price · USD

0.05

-0.00 (-1.96%)

At close: Jun 09, 2025, 12:40 PM

Vincerx Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	4.44M	4.99M	2.94M	8.01M	5.19M	12.85M	15.08M	6.68M	4.49M	11.66M	45.8M	80.86M	96.49M	111.46M	122.8M	85.62M	53.35M
Short-Term Investments	n/a	n/a	7.14M	8.4M	n/a	n/a	5.72M	20.68M	35.28M	40.8M	20.17M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	1.33M	1.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.18M
Other Long-Term Assets	n/a	1.59M	1.68M	122K	138K	1.16M	874K	624K	354K	81K	1.64M	1.64M	1.87M	1.65M	1.76M	187K	-7.96M
Receivables	n/a	1.04M	1.06M	1.02M	n/a	n/a	1.05M	1.38M	n/a	1.37M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	392K	-748K	n/a	-1.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	249K	128K	316K	334K	1.87M	1.9M	641K	2.43M	3.43M	439K	810K	682K	310K	200K	n/a	n/a	n/a
Total Current Assets	4.69M	6.41M	11.75M	18.28M	7.68M	14.73M	22.82M	31.81M	44.01M	55.96M	67.25M	82.39M	98.06M	111.84M	123.25M	86.5M	54.41M
Property-Plant & Equipment	n/a	n/a	1.52M	1.79M	2.06M	2.33M	2.58M	2.84M	3.09M	3.24M	3.48M	3.72M	3.95M	4.18M	4.42M	4.45M	3.37M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	1.59M	3.2M	3.24M	3.41M	3.48M	3.46M	3.46M	3.44M	3.32M	5.12M	5.36M	5.82M	5.83M	6.18M	4.63M	3.59M
Total Assets	4.69M	8.01M	14.95M	21.53M	11.08M	18.22M	26.28M	35.27M	47.45M	59.29M	72.38M	87.74M	103.88M	117.68M	129.43M	91.14M	58M
Account Payables	2.27M	2.03M	1.96M	1.54M	2.31M	2.5M	3.06M	3.53M	6.17M	3.06M	4.39M	5.12M	3.39M	2.02M	2.26M	1.83M	461K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	4.53M	4.29M	n/a	n/a	n/a	n/a	n/a	4.71M	4.67M	2.4M	1.39M
Short-Term Debt	n/a	n/a	n/a	n/a	1.2M	1.16M	n/a	1.09M	1.06M	1.02M	999K	968K	852K	738K	532K	360K	96K
Other Current Liabilities	351K	8K	463K	132K	4.2M	-466K	132K	-848K	-932K	2.16M	-886K	-934K	384K	8.22M	17.17M	10.74M	27.13M
Total Current Liabilities	2.62M	5.28M	5.42M	5.33M	10.63M	5.61M	8.85M	9.16M	10.71M	9.16M	9.95M	10.45M	11.53M	13.92M	25.16M	15.68M	29.17M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	50K	50K	50K	50K	50K	50K	50K	50K	50K	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	415K	747K	1.07M	1.39M	1.69M	1.98M	2.27M	2.46M	2.72M	2.93M	3.19M	3.44M	3.64M	3.86M	3.28M
Total Liabilities	2.62M	5.28M	5.84M	6.08M	11.71M	7M	10.54M	11.14M	12.98M	11.62M	12.67M	13.38M	14.71M	17.36M	28.8M	19.54M	32.45M
Total Debt	n/a	n/a	1.64M	1.93M	2.22M	2.5M	2.77M	3.02M	3.28M	3.44M	3.67M	3.9M	4.04M	4.17M	4.17M	4.22M	3.37M
Common Stock	1K	n/a	3K	3K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	1K	1K
Retained Earnings	-194.19M	-189.19M	-181.19M	-173.35M	-171.54M	-159.11M	-156.54M	-146.83M	-135.68M	-121.34M	-107.69M	-90.82M	-72.39M	-55.97M	-49.5M	-24.98M	-22.94M
Comprehensive Income	170K	119K	104K	24K	60K	8K	52K	69K	35K	-26K	-63K	4K	-6K	-21K	-19K	-0.00	-8.18M
Shareholders Equity	2.07M	2.72M	9.11M	15.45M	-622K	11.22M	15.74M	24.14M	34.47M	47.67M	59.71M	74.36M	89.17M	100.32M	100.63M	71.59M	25.55M
Total Investments	n/a	n/a	7.14M	9.73M	1.21M	n/a	5.72M	20.68M	35.28M	40.8M	20.17M	n/a	n/a	n/a	n/a	n/a	8.18M